The portfolio seeks to invest in small-cap companies where we believe the valuation does not reflect the quality and normal ...

Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired ...

Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical ...

If you suffered losses exceeding $75,000 in ICON between July 27, 2023 and October 23, 2024 and would like to discuss your ...

Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve Worland, Ph.D. as Chief ...

Katherine Stueland, GeneDx CEO, joins 'Closing Bell' to discuss company earnings and the future of genome sequencing.

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive ...

Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated ...

USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...

The good news is biosolutions can help. Biosolutions – biological technologies that use enzymes, microbes and functional ...

The Noonan lab at Yale University is focused on understanding how HARs contribute to the evolution of uniquely human brain features.

The co-chief investment officers at Neuberger Berman see a new dynamic in the stock market as investors move on from inflation worries You have no doubt seen warnings that the U.S. stock market is ...